Table 6.
Percentage antibiotic susceptibility of emerging microorganisms isolated in UTI *.
| Agent | Susceptibility (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
A. massili-ensis (n = 3) |
A. schaalii (n = 4) |
A. urinae (n = 18) |
A. sanguinicola (n = 10) |
A. viridans (n = 1) |
Corynebacterium (n = 22) |
F. hominis (n = 2) |
Lactobaci-llus** (n = 23) |
S. group bovis (n = 91) |
S. group viridans (n = 6) |
||
| Pen | P | 100 | 100 | 90 | 100 | 0 | 8 | 100 | 90 | 33 | |
| AMP | 100 | 100 | 100 | 0 | 70 | 100 | 50 | ||||
| AMC | 100 | 100 | |||||||||
| TZP | 100 | ||||||||||
| Cef | CTX | 100 | 100 | 100 | 100 | 14 | 100 | 100 | |||
| CFM | 0 | ||||||||||
| Carba | IPM | 100 | 100 | 0 | 70 | ||||||
| MEM | 100 | 90 | 100 | 29 | 100 | 100 | |||||
| Quino | CIP | 88 | 22 | 100 | 27 | ||||||
| LEV | 0 | 0 | 100 | 0 | 77 | 50 | |||||
| MXF | 33 | 100 | |||||||||
| Amg | CN | 0 | 69 | ||||||||
| Gcp | VA | 100 | 100 | 100 | 100 | 100 | 100 | ||||
| Tetra | TE | 100 | 100 | 92 | 21 | 100 | |||||
| Ntm | MTZ | 0 | 0 | 0 | |||||||
| Rif | RD | 100 | 100 | 100 | |||||||
| Various | SXT | 0 | 0 | ||||||||
| FOS | 0 | 0 | 99 | ||||||||
| F | 100 | 100 | 100 | ||||||||
* Antibiogram not performed for A. turicensis (n = 4), A. omnicolens (n = 1), or G. vaginalis (n = 38). ** Lactobacillus: crispatus, delbrueckii, fermentum, gasseri, jensenii, rhamnosus. Penicillins (Pen), Cephalosporins (Cef), Carbapenems (Carba), Quinolones (Quino), Aminoglycosides (Amg), Glycopeptides (Gcp), Tetracycline (Tetra), Nitroimidazole (Ntm), Rifampicin (Rif), Sulfamides (Sulf), Amoxicillin-Clavulanic (AMC), Ampicillin (AMP), Penicillin (P), Piperacillin-Tazobactam (TZP), Cefotaxime (CTX), Cefixime (CFM), Imipenem (IPM), Meropenem (MEM), Ciprofloxacin (CIP), Levofloxacin (LEV), Moxifloxacin (MXF), Gentamicin (CN), Teicoplanin (TEC), Vancomycin (VA), Tetracycline (TE), Metronidazole (MTZ), Rifampicin (RD), Trimethoprim-Sulfamethoxazole (SXT), Fosfomycin (FOS), Nitrofurantoin (F).